Ultragenyx Pharmaceutical Inc 's ability to collect accounts receivable sequentially worsen to 4.53, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Ultragenyx Pharmaceutical Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 81 days, from 75 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 388 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2503, from overall ranking in the second quarter 2026 at 2573.

What is Receivable Turnover Ratio?
What is Ultragenyx Pharmaceutical Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RARE Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	47.5 %	60.69 %	22.42 %	29.72 %	20.62 %
Y / Y Revenue Change	8.17 %	28.53 %	-2.36 %	25.72 %	14.65 %
Receivable Turnover Ratio (TTM)	4.53	4.85	5.19	5.45	5.51
RARE's Total Ranking	# 2503	# 2573	# 1805	# 853	#
Accounts Receivable average collection period days	81	75	70	67	66
Seq. Receivable Change	-17 %	65.29 %	-23.42 %	40.39 %	-9.58 %
Seq. Revenue Change	-19.16 %	57.35 %	-34.39 %	29.6 %	-3.94 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 118
Healthcare Sector	# 389
Overall Market	# 2503

Receivable Turnover Ratio Statistics
High	Average	Low
14.72	7.59	3.97
(Mar 31 2021)		(Jun 30 2018)

RARE Company Profile • Back to RARE Efficiency Comparisons • Compare RARE Receivables Turnover Ratio to its Competitors

Financial Statements
Ultragenyx Pharmaceutical Inc 's Accounts Receivable	$ 166 Millions	Visit RARE's Balance sheet
Ultragenyx Pharmaceutical Inc 's Sales TTM	$ 730 Millions	Visit RARE's Income Statement
Sources of RARE's Revenues		Visit RARE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RARE's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RARE's Growth Rates	RARE's Roa	RARE's Inventory Turnover Ratio	RARE's Dividend Comparisons
RARE's Profitability Ratios	RARE's Roi	RARE's Asset Turnover Ratio	RARE's Dividend Growth
RARE's Valuation Ratios	RARE's Roe	RARE's Financial Strength Ratios	RARE's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Caredx Inc	11.75	$ 497.396 Millions	$ 42.330 Millions
Teladoc Health Inc	11.50	$ 2,468.143 Millions	$ 214.604 Millions
Iqvia Holdings Inc	10.43	$ 17,311.000 Millions	$ 1,659.500 Millions
Encompass Health Corporation	9.41	$ 6,338.100 Millions	$ 673.625 Millions
Bausch Health Companies Inc	9.15	$ 11,113.000 Millions	$ 1,215.000 Millions
Pacs Group Inc	8.88	$ 5,705.049 Millions	$ 642.729 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Pediatrix Medical Group Inc	8.57	$ 1,959.124 Millions	$ 228.471 Millions
Tenet Healthcare Corp	8.54	$ 22,154.000 Millions	$ 2,593.250 Millions
Brightspring Health Services Inc	8.50	$ 9,479.144 Millions	$ 1,114.763 Millions
Sotera Health Company	8.49	$ 1,230.250 Millions	$ 144.974 Millions
Tactile Systems Technology Inc	8.23	$ 357.176 Millions	$ 43.385 Millions
Penumbra Inc	8.22	$ 1,560.334 Millions	$ 189.735 Millions
Inspire Medical Systems inc	8.15	$ 882.194 Millions	$ 108.207 Millions
Adapthealth Corp	8.14	$ 3,152.043 Millions	$ 387.280 Millions
Rhythm Pharmaceuticals Inc	8.03	$ 280.748 Millions	$ 34.950 Millions
Alphatec Holdings Inc	7.91	$ 839.652 Millions	$ 106.153 Millions
Exelixis Inc	7.89	$ 2,496.861 Millions	$ 316.636 Millions
Henry Schein Inc	7.84	$ 13,734.000 Millions	$ 1,752.000 Millions
Idexx Laboratories Inc	7.78	$ 4,663.675 Millions	$ 599.701 Millions
Madrigal Pharmaceuticals Inc	7.70	$ 1,427.940 Millions	$ 185.380 Millions
Pulmonx Corporation	7.56	$ 89.176 Millions	$ 11.791 Millions
Merit Medical Systems Inc	7.53	$ 1,612.236 Millions	$ 214.065 Millions
Cerus Corporation	7.48	$ 226.798 Millions	$ 30.308 Millions
Insmed Inc	7.45	$ 1,479.040 Millions	$ 198.502 Millions
Novocure Limited	7.44	$ 725.388 Millions	$ 97.525 Millions
Intuitive Surgical Inc	7.44	$ 12,115.600 Millions	$ 1,629.350 Millions
Quest Diagnostics Inc	7.43	$ 11,841.000 Millions	$ 1,593.250 Millions
Travere Therapeutics Inc	7.32	$ 651.034 Millions	$ 88.900 Millions

Date modified: 2026-11-05T13:25:25+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.